Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: PVR
Name: PVR cell adhesion molecule
Location: 19q13.31
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT00370201 Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment View
NCT00373282 Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy View
NCT00739375 The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension View
NCT04915300 Apabetalone for Pulmonary Arterial Hypertension View
NCT01165047 Nitric Oxide GeNO Nitrosyl Delivery System View
NCT02790918 Diagnosis of Pulmonary Hypertension Using Cardiac Magnetic Resonance Images View
NCT01224210 Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial View
NCT03632772 Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP View
NCT01959568 Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery View
NCT03053349 Ex Vivo Lung Perfusion in Bergamo Lung Transplant Program View
NCT03558919 Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder View
NCT03626259 LosartanAmlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension View
NCT03728049 Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes View
NCT04416685 A New Anatomical Classification of Portal Vein Location of Pancreas Tumors View
NCT04780932 Initial Dual Oral Combination Therapy Versus Standard-of-care Initial Oral Monotherapy Prior to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension View
NCT04891991 Intravitreal Infliximab for Proliferative Vitreoretinopathy View
NCT06051396 Phenotyping of the Out-of-proportion Pulmonary Hypertension View
NCT05922631 Effect of APRV vs LTV on Right Heart Function in ARDS Patients a Single-center Randomized Controlled Study View
NCT02275793 The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure View
NCT03009968 Reducing Postoperative Catheterization View
NCT05574855 Evaluation of Haemodynamic in Neonates Treated With Hypothermia View
NCT04331301 Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH View
NCT00348413 Thyroid Treatment Trial View
NCT00371020 The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR View
NCT00370760 Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy PVR View
NCT04490876 Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Proliferative Vitreoretinopathy View
NCT01554774 Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease View
NCT00434902 Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease View
NCT00690950 A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia BPH When Switching Subjects From Proscar to Avodart View
NCT01597934 Antiviral Efficacy of Switching to ETV Plus TDF View
NCT02648984 Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect View
NCT00878878 Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure PASP and Pulmonary Vascular Resistance PVR View
NCT01657409 Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome View
NCT01117649 Plasma Volume Replacement PVR Therapy With Colloid and Crystalloid Solutions View
NCT04732221 A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension INSIGNIA-PAH Phase 23 Study of an Inhaled sGC Stimulator in PAH MK-5475-007 View
NCT01205620 IRB-HSR 15084 A Prospective Unblinded Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery View
NCT01212523 Effects of Propofol and Isoflurane on Pulmonary Vascular Resistance View
NCT01265888 Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl View
NCT04830878 Methotrexate For The Prevention and Treatment of Proliferative Vitreoretinopathy in Pediatric Patients View
NCT01445028 Isotretinoin for Proliferative Vitreoretinopathy View
NCT01431313 Inhaled Nitrite in Subjects With Pulmonary Hypertension View
NCT04052243 Hemodynamic Effects of BPA at Rest and During Exercise in CTEPH View
NCT04965493 A Trial of Pirtobrutinib LOXO-305 Plus Venetoclax and Rituximab PVR Versus Venetoclax and Rituximab VR in Previously Treated Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL View
NCT02951130 Milrinone in Congenital Diaphragmatic Hernia View
NCT01725256 A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension PAH View
NCT01934647 Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension PAH MK-8892-003 View
NCT02006303 Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients View
NCT03213522 Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy View
NCT03372096 LC Bead LUMI for Prostatic Artery Embolization View
NCT02078557 A Multiple Dose Titration Study of MK-8892 in Participants With Pulmonary Hypertension and Left Heart Disease MK-8892-007 View
NCT02129179 The Effect of Glucagon-Like Peptide-1 GLP-1 on Pulmonary Vascular Resistance PVR in Patients With Heart Failure View
NCT05524558 Assessment of the Hemodynamic Effects of PEEP According to Alveolar Recruitment During the ARDS View
NCT05538156 Internal Limiting Membrane Peeling in Retinal Detachment Surgery View
NCT03809650 A Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension CTEPH View
NCT02482402 Iloprost for Bridging to Heart Transplantation in PH View
NCT05612178 A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy View
NCT03551574 Adaptive Optics in PVR View
NCT02554903 Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device Implantation View
NCT02634203 Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension View
NCT02683408 Diosmiplex Vasculera in Primary and Secondary Raynauds Phenomenon View
NCT05737940 A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 View
NCT03634072 Pediatric REPlAcement of the PulmonaRy ValvE in Tetralogy of Fallot - View
NCT04280770 23-gauge Pars Plana Vitrectomy With Silicone Oil Injectionsilicone Oil Injection With Surgical View
NCT02865031 Dacorin for Proliferative Vitreoretinopathy View
NCT05343637 A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension View
NCT02968901 Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension OPTIMA View
NCT03031717 Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS View
NCT04482543 Repeated Methotrexate for Proliferative Vitreoretinopathy Grade C View
NCT03119428 A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors View
NCT04370873 MK-5475 in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease PH-COPD MK-5475-006 View
NCT04570787 Bladder Catheterization After Mini-PCNL View
NCT03208205 Outcomes of Vitrectomy in Pediatric Retinal Detachment With Proliferative Vitreoretinopathy View
NCT04520789 Early Prevention Strategies of Severe Proliferative Vitreoretinopathy Base on Precision Diagnosis of Single Cell Sequencingvitreoretinopathy View
NCT03273257 Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy PEA Bridging Study View
NCT04580147 Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair View
NCT03365479 Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension View
NCT03565211 Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures View
NCT06289205 Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy View
NCT06323512 Pulmonary Arteyr Denervation for HF Without PH View
NCT06372886 Clinical Outcomes of Preservation Versus Resection of PortalSuperior Mesenteric Vein During Pancreaticoduodenectomy in Pancreatic Cancer Patients Who Respond to Neoadjuvant Treatment View
NCT03737656 Characterization of the Pharmacokinetics of a Vaginal Ring With 20 g Progesterone in Post-menopausal Women View
NCT03814317 Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension View
NCT04945460 A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF MK-7962-007A011-16 View
NCT06475781 Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD View
NCT05128929 Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease The SATURN Study View
NCT04136366 The GUARD Trial - Part 1 A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy View
NCT04155593 In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder View
NCT04168255 Double Retinal Tamponade for Retinal Detachment With PVR and Inferior Breaks View
NCT05660447 A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR View
NCT01860586 Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment View
NCT04628975 PeRfusion Emergency VEiNlite Transillumination View
NCT05841004 Clinical Trial of New Single-use Compact Intermittent Catheter View
NCT04677608 Pulmonary Hypertension Modality of Death and Validation of REVEAL Risk Score View
NCT04715971 Urinary Retention on an Acute Geriatric Hospitalisation Unit View
NCT05036135 A Study of AV-101 Dry Powder Inhaled Imatinib in Patients With Pulmonary Arterial Hypertension PAH View
NCT05295823 Patient Self Measurement of Post-Void Residual Bladder Volume PVR Using Ultrasound View
NCT06541574 Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair FIXER Trial View
NCT05378425 A Study of NTX-1088 a Monoclonal Antibody Targeting the Poliovirus Receptor PVR CD155 as Monotherapy and Combined With Pembrolizumab View
NCT05523869 Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy View
NCT06528613 Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with SolifenacinTamsulosin View
NCT05768230 Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV View
NCT02734953 Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH View
NCT00913510 Efficacy of Clean Intermittent Catheterization CIC in Multiple Sclerosis MS Patients With Bladder Dysfunction View
NCT02050399 Cardiovascular Oscillations in Coronary Patients With and Without Type 2 Diabetes View
NCT01072643 Sedation With Dexmedetomidine During Cardiac Catheterization View
NCT06350773 Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension View
NCT06425419 The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy View
NCT02906436 Ex-Vivo Lung Reconditioning View
NCT05415826 Ozurdex in Reducing PVR After Vitreotomy in PDR View
NCT03638908 Fluoxetine in Pulmonary Arterial Hypertension PAH Trial View
NCT02675543 Vitreous Inflammation in Standard and Heavy Silicone Oil View
NCT00077012 Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia View
NCT01028651 A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension View
NCT00000140 The Silicone Study View
NCT02186691 Right and Left Ventricle Remodeling Predictors After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot View
NCT01121458 Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed View
NCT02234141 Selonsertib in Adults With Pulmonary Arterial Hypertension View
NCT04107896 Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia BPH View
NCT00075179 Natrecor in Pulmonary Hypertension View
NCT00112320 Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of Fallot View
NCT00384163 Adult Pulmonary Valve Replacement A Simple and Reproducible Technique View
NCT00617305 Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor PDE5i Therapy in Pulmonary Arterial Hypertension ATHENA-1 View
NCT02595541 Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension View
NCT02834559 Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment View
NCT02873026 Adjunctive Steroid Combination in Ocular Trauma ASCOT Study View
NCT02885636 Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF BEAT HFpEF A Randomized Controlled Trial View
NCT03727776 Adrenocorticotropic Hormone ACTH for Post-op Inflammation in Proliferative Vitreoretinopathy PVR View
NCT03754660 This Study Tests the Safety of Inhaled BAY1237592 How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension PAH and Chronic Thromboembolic Pulmonary Hypertension CTEPH View
NCT03841344 Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH View
NCT04030221 Pressure Gradient for Venous Return in Predicting Fluid Responsiveness in Patients Undergoing Laparoscopic Surgery View